Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecu...
Q1 2026
May 12, 2026
FY 2025
Mar 25, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 12, 2025